Delivering The Dosage

For more than 30 years, asthmatics have walked around with portable inhalers in their pockets. Taking a puff of medication from an inhaler, patients can stifle an asthma attack. If they inhale medicine daily, they may even prevent asthma attacks entirely. But there's a problem. Studies suggest that many asthma patients use inhalers incorrectly and end up with less medicine than they need. They might inhale their medication too quickly, for example. In many cases, asthma patients end up swallow

Written byKathryn Brown
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For more than 30 years, asthmatics have walked around with portable inhalers in their pockets. Taking a puff of medication from an inhaler, patients can stifle an asthma attack. If they inhale medicine daily, they may even prevent asthma attacks entirely.

But there's a problem. Studies suggest that many asthma patients use inhalers incorrectly and end up with less medicine than they need. They might inhale their medication too quickly, for example. In many cases, asthma patients end up swallowing the medicine rather than breathing it into their lungs.

In response, many companies are working on asthma drugs that would be taken as pills rather than inhaled. But researchers at Aradigm Corp. in Hayward, Calif., say they've got a better solution: automated inhalers. The Food and Drug Administration (FDA) recently approved Aradigm's SmartMist inhaler system, which should hit pharmacy shelves later this year.

"Taking [asthma] drugs by inhalation is effective ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies